Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.
Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, Furlan A, Gilron I, Gordon A, Morley-Forster PK, Sessle BJ, Squire P, Stinson J, Taenzer P, Velly A, Ware MA, Weinberg EL, Williamson OD; Canadian Pain Society.
Moulin D, et al.
Pain Res Manag. 2014 Nov-Dec;19(6):328-35. doi: 10.1155/2014/754693.
Pain Res Manag. 2014.
PMID: 25479151
Free PMC article.
Recommended fourth-line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacosamide), tapentadol and botulinum toxin. There is support for some analgesic combinations in selected NeP conditions. ...
Recommended fourth-line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacosamide), …